Medicine and Dentistry
Nonmyeloablative Stem Cell Transplantation
100%
Paroxysmal Nocturnal Hemoglobinuria
100%
Chimera
60%
Transplantation
40%
Hematopoiesis
40%
Flow Cytometry
20%
Disease
20%
Recurrent Disease
20%
Conditioning
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Cyclosporine
20%
Hematopoietic Stem Cell
20%
Short Tandem Repeat
20%
Peripheral Blood Mononuclear Cell
20%
Acute Kidney Injury
20%
Phlebothrombosis
20%
Cladribine
20%
Hemolytic Anemia
20%
Busulfan
20%
Peripheral Blood Stem Cell
20%
Graft Versus Host Reaction
20%
Human Leukocyte Antigen
20%
Thymocyte Antibody
20%
Keyphrases
Non-myeloablative Transplantation
100%
Paroxysmal Nocturnal Hemoglobinuria
100%
Chimerism
33%
Hematopoiesis
33%
Flow Cytometry
16%
Advanced Age
16%
Peripheral Blood Mononuclear Cells
16%
Day 14
16%
Cyclosporine
16%
Conditioning Regimen
16%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Treatment Toxicity
16%
Organ Dysfunction
16%
Donor Type
16%
Graft-versus-host Disease (GvHD)
16%
Acute Renal Failure
16%
Busulfan
16%
Hematopoietic Stem Cells
16%
Hemolytic Anemia
16%
Antithymocyte Globulin
16%
Venous Thrombosis
16%
Cladribine
16%
Peripheral Blood Stem Cells
16%
Stem Cell Deficiency
16%
Human Leukocyte Antigen
16%
Donor chimerism
16%
Short Tandem Repeat Analysis
16%
Transplant-related Mortality
16%
Pharmacology, Toxicology and Pharmaceutical Science
Paroxysmal Nocturnal Hemoglobinuria
100%
Flow Cytometry
20%
Disease
20%
Leporidae
20%
Recurrent Disease
20%
Acute Kidney Failure
20%
Ciclosporin
20%
Busulfan
20%
Hemolytic Anemia
20%
Graft Versus Host Reaction
20%
Vein Thrombosis
20%
Cladribine
20%